Clinical application of vascular regenerative therapy for peripheral artery disease

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Suzuki, Hiroshi ^a   Iso, Yoshitaka ^b  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b Showa University Fujigaoka Rehabilitation Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL; BONE MARROW CELL; HUMAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATION; REVIEW;

ANIMALS; BONE MARROW CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; REGENERATION;

EID: 84893777329     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/179730     Document Type: Review

References (45)

1. Criqui M. H., Fronek A., Barrett-Connor E., The prevalence of peripheral arterial disease in a defined population. (Pubitemid 15133809)
2. Fowkes F. G. R., Housley E., Cawood E. H. H., Macintyre C. C. A., Ruckley C. V., Prescott R. J., Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology 1991 20 2 384 392 2-s2.0-0025923717
3. McGrae McDermott M., Kerwin D. R., Liu K., Martin G. J., O'Brien E., Kaplan H., Greenland P., Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. Journal of General Internal Medicine 2001 16 6 384 390 2-s2.0-0035722894 10.1046/j.1525-1497.2001.016006384.x (Pubitemid 34205656)
4. Belch J. J. F., Topol E. J., Agnelli G., Bertrand M., Califf R. M., Clement D. L., Creager M. A., Easton J. D., Gavin J. R. III, Greenland P., Hankey G., Hanrath P., Hirsch A. T., Meyer J., Smith S. C., Sullivan F., Weber M. A., Critical issues in peripheral arterial disease detection and management: a call to action. Archives of Internal Medicine 2003 163 8 884 892 2-s2.0-0037471546 10.1001/archinte.163.8.884 (Pubitemid 36519734)
5. Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G. R., Inter-society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery 2007 45 1 S5 S67 2-s2.0-33846497950 10.1016/j.jvs.2006.12.037 (Pubitemid 46151680)
6. Hirsch A. T., Haskal Z. J., Hertzer N. R., Bakal C. W., Creager M. A., Halperin J. L., Hiratzka L. F., Murphy W. R. C., Olin J. W., Puschett J. B., Rosenfield K. A., Sacks D., Stanley J. C., Taylor L. M. Jr., White C. J., White J., White R. A., ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology. Journal of Vascular and Interventional Radiology 2006 17 9 1383 1398 2-s2.0-33748855436 10.1097/01.RVI.0000240426.53079.46 (Pubitemid 44418947)
7. Weitz J. I., Byrne J., Patrick Clagett G., Farkouh M. E., Porter J. M., Sackett D. L., Eugene Strandness D. Jr., Taylor L. M., Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996 94 11 3026 3049 2-s2.0-0029850227 (Pubitemid 26411793)
8. Rowlands T. E., Donnelly R., Medical therapy for intermittent claudication. European Journal of Vascular and Endovascular Surgery 2007 34 3 314 321 2-s2.0-34547582817 10.1016/j.ejvs.2007.04.001 (Pubitemid 47194422)
9. Becker G. J., Palmaz J. C., Rees C. R., Ehrman K. O., Lalka S. G., Dalsing M. C., Cikrit D. F., McLean G. K., Burke D. R., Richter G. M., Noeldge G., Garcia O., Waller B. F., Castaneda-Zuniga W. R., Angioplasty-induced dissections in human iliac arteries: management with palmaz balloon-expandable intraluminal stents. Radiology 1990 176 1 31 38 2-s2.0-0025324353 (Pubitemid 20208102)
10. Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G. R., Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular and Endovascular Surgery 2007 33 1 S1 S75 2-s2.0-33845241195 10.1016/j.ejvs.2006.09.024 (Pubitemid 46068992)
11. Iida O., Nakamura M., Yamauchi Y., Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE Registry, a Prospective, Multicenter Study in Japan with 12-month follow-up. Circulation Cardiovascular Intervention 2013 6 1 68 76
12. Isner J. M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., Symes J. F., Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. The Lancet 1996 348 9024 370 374 2-s2.0-15844420661 10.1016/S0140- 6736(96)03361-2 (Pubitemid 26261511)
13. Iba O., Matsubara H., Nozawa Y., Fujiyama S., Amano K., Mori Y., Kojima H., Iwasaka T., Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002 106 15 2019 2025 2-s2.0-0037044403 10.1161/01.CIR.0000031332.45480.79 (Pubitemid 35176311)
14. Kalka C., Masuda H., Takahashi T., Kalka-Moll W. M., Silver M., Kearney M., Li T., Isner J. M., Asahara T., Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3422 3427 2-s2.0-0034724335 10.1073/pnas.070046397 (Pubitemid 30183318)
15. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T., Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. The Lancet 2002 360 9331 427 435 2-s2.0-0037055666 10.1016/S0140-6736(02)09670-8
16. Matoba S., Tatsumi T., Murohara T., Imaizumi T., Katsuda Y., Ito M., Saito Y., Uemura S., Suzuki H., Fukumoto S., Yamamoto Y., Onodera R., Teramukai S., Fukushima M., Matsubara H., Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [TACT] trial) in patients with chronic limb ischemia. American Heart Journal 2008 156 5 1010 1018 2-s2.0-54349125024 10.1016/j.ahj.2008.06.025
17. Marshall E., Gene therapy death prompts review of adenovirus vector. Science 1999 286 5448 2244 2245 2-s2.0-0033579358 10.1126/science.286.5448.2244 (Pubitemid 30016842)
18. Gansbacher B., Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of gene therapy (ESGT). The Journal of Gene Medicine 2003 5 3 261 262 2-s2.0-0043033652
19. Takeshita S., Zheng L. P., Brogi E., Kearney M., Pu L.-Q., Bunting S., Ferrara N., Symes J. F., Isner J. M., Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. Journal of Clinical Investigation 1994 93 2 662 670 2-s2.0-0028344109
20. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., Isner J. M., Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998 97 12 1114 1123 2-s2.0-0032583951 (Pubitemid 28152883)
21. Morishita R., Aoki M., Hashiya N., Makino H., Yamasaki K., Azuma J., Sawa Y., Matsuda H., Kaneda Y., Ogihara T., Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004 44 2 203 209 2-s2.0-3543025721 10.1161/01.HYP.0000136394. 08900.ed (Pubitemid 39014240)
22. Shigematsu H., Yasuda K., Iwai T., Sasajima T., Ishimaru S., Ohashi Y., Yamaguchi T., Ogihara T., Morishita R., Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Therapy 2010 17 9 1152 1161 2-s2.0-77956611658 10.1038/gt.2010.51
23. Masaki I., Yonemitsu Y., Yamashita A., Sata S., Tanii M., Komori K., Nakagawa K., Hou X., Nagai Y., Hasegawa M., Sugimachi K., Sueishi K., Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circulation Research 2002 90 9 966 973 2-s2.0-0037123968 10.1161/01.RES.0000019540.41697.60 (Pubitemid 34633862)
24. Onimaru M., Yonemitsu Y., Tanii M., Nakagawa K., Masaki I., Okano S., Ishibashi H., Shirasuna K., Hasegawa M., Sueishi K., Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circulation Research 2002 91 10 923 930 2-s2.0-0037112560 10.1161/01.RES.0000043281.66969.32 (Pubitemid 35373592)
25. Yonemitsu Y., Matsumoto T., Itoh H., DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial. Molecular Therapy 2013 21 3 707 714
26. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 5302 964 967 2-s2.0-0031019745 10.1126/science.275.5302.964 (Pubitemid 27087709)
27. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K.-I., Eguchi H., Onitsuka I., Matsui K., Imaizumi T., Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation 2000 105 11 1527 1536 2-s2.0-0034129573 (Pubitemid 30390303)
28. Kawamoto A., Katayama M., Handa N., Kinoshita M., Takano H., Horii M., Sadamoto K., Yokoyama A., Yamanaka T., Onodera R., Kuroda A., Baba R., Kaneko Y., Tsukie T., Kurimoto Y., Okada Y., Kihara Y., Morioka S., Fukushima M., Asahara T., Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009 27 11 2857 2864 2-s2.0-73149090351 10.1002/stem.207
29. Kinoshita M., Fujita Y., Katayama M., Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis 2012 224 2 440 445
30. Walter D. H., Krankenberg H., Balzer J. O., Kalka C., Baumgartner I., Schlüter M., Tonn T., Seeger F., Dimmeler S., Lindhoff-Last E., Zeiher A. M., Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation 2011 4 1 26 37 2-s2.0-79954448926 10.1161/ CIRCINTERVENTIONS.110.958348
31. Tateno K., Minamino T., Toko H., Akazawa H., Shimizu N., Takeda S., Kunieda T., Miyauchi H., Oyama T., Matsuura K., Nishi J.-I., Kobayashi Y., Nagai T., Kuwabara Y., Iwakura Y., Nomura F., Saito Y., Komuro I., Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circulation Research 2006 98 9 1194 1202 2-s2.0-33745028454 10.1161/01.RES. 0000219901.13974.15 (Pubitemid 43948106)
32. Moriya J., Minamino T., Tateno K., Shimizu N., Kuwabara Y., Sato Y., Saito Y., Komuro I., Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circulation 2009 2 3 245 254 2-s2.0-77953677951 10.1161/CIRCINTERVENTIONS.108.799361
33. Kawamura A., Horie T., Tsuda I., Abe Y., Yamada M., Egawa H., Iida J.-I., Sakata H., Onodera K., Tamaki T., Furui H., Kukita K., Meguro J.-I., Yonekawa M., Tanaka S., Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. Journal of Artificial Organs 2006 9 4 226 233 2-s2.0-33845607696 10.1007/s10047-006-0351-2 (Pubitemid 44954312)
34. Onodera R., Teramukai S., Tanaka S., Kojima S., Horie T., Matoba S., Murohara T., Matsubara H., Fukushima M., Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis. Bone Marrow Transplantation 2011 46 2 278 284 2-s2.0-79951680403 10.1038/bmt.2010.110
35. Horie T., Onodera R., Akamastu M., Ichikawa Y., Hoshino J., Kaneko E., Iwashita C., Ishida A., Tsukamoto T., Teramukai S., Fukushima M., Kawamura A., Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis 2010 208 2 461 466 2-s2.0-74749107032 10.1016/j.atherosclerosis.2009.07.050
36. Iso Y., Spees J. L., Serrano C., Bakondi B., Pochampally R., Song Y.-H., Sobel B. E., Delafontaine P., Prockop D. J., Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochemical and Biophysical Research Communications 2007 354 3 700 706 2-s2.0-33846639224 10.1016/j.bbrc.2007.01.045 (Pubitemid 46186241)
37. Amado L. C., Saliaris A. P., Schuleri K. H., St. John M., Xie J.-S., Cattaneo S., Durand D. J., Fitton T., Kuang J. Q., Stewart G., Lehrke S., Baumgartner W. W., Martin B. J., Heldman A. W., Hare J. M., Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 2005 102 32 11474 11479 2-s2.0-23844475067 10.1073/pnas.0504388102 (Pubitemid 41153844)
38. Lim S. Y., Kim Y. S., Ahn Y., Jeong M. H., Hong M. H., Joo S. Y., Nam K. I., Cho J. G., Kang P. M., Park J. C., The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovascular Research 2006 70 3 530 542 2-s2.0-33646676295 10.1016/j.cardiores.2006.02.016 (Pubitemid 43732376)
39. Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T., Kangawa K., Kitamura S., Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovascular Research 2005 66 3 543 551 2-s2.0-19444380789 10.1016/j.cardiores.2005.02.006 (Pubitemid 40725766)
40. Lu D., Chen B., Liang Z., Deng W., Jiang Y., Li S., Xu J., Wu Q., Zhang Z., Xie B., Chen S., Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Research and Clinical Practice 2011 92 1 26 36 2-s2.0-79954575328 10.1016/j.diabres.2010.12.010
41. Ishikane S., Ohnishi S., Yamahara K., Sada M., Harada K., Mishima K., Iwasaki K., Fujiwara M., Kitamura S., Nagaya N., Ikeda T., Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008 26 10 2625 2633 2-s2.0-55049135564 10.1634/stemcells.2008-0236
42. Yurugi-Kobayashi T., Itoh H., Yamashita J., Yamahara K., Hirai H., Kobayashi T., Ogawa M., Nishikawa S., Nishikawa S.-I., Nakao K., Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage. Blood 2003 101 7 2675 2678 2-s2.0-0038526325 10.1182/blood-2002-06-1877 (Pubitemid 36857629)
43. Takahashi K., Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 126 4 663 676 2-s2.0-33747195353 10.1016/j.cell.2006.07.024 (Pubitemid 44233629)
44. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., Yamashita J. K., Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008 118 5 498 506 2-s2.0-49649120250 10.1161/CIRCULATIONAHA.108.769562
45. Suzuki H., Shibata R., Kito T., Ishii M., Li P., Yoshikai T., Nishio N., Ito S., Numaguchi Y., Yamashita J. K., Murohara T., Isobe K., Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells. BMC Cell Biology 2010 11, article 72 2-s2.0-77956800940 10.1186/1471-2121-11-72